Ovarian stimulation and PGT-A outcomes with random start letrozole protocol for fertility preservation in breast cancer patients
Yükleniyor...
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Oxford University Press
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Study question Data on random start letrozole ovarian stimulation (RSL) in breast cancer patients is scant. We studied RSL outcomes from a single-center with fertility preservation expertise. Summary answer RSL appears to result in high oocyte and embryo/blastocyst yield, with an age-appropriate aneuploidy rate.
Açıklama
Anahtar Kelimeler
Kaynak
Human Reproduction
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
37
Sayı
Künye
Arkfeld, C., Gayete-Lafuente, S., Turan, V., & Oktay, K. (2022). Ovarian stimulation and PGT-A outcomes with random start letrozole protocol for fertility preservation in breast cancer patients. Human Reproduction, 37(Supplement 1). https://doi.org/10.1093/humrep/deac107.449
